Cerner (NASDAQ:CERN) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.57-2.73 for the period, compared to the Thomson Reuters consensus estimate of $2.67. The company issued revenue guidance of $5.45-5.65 billion, compared to the consensus revenue estimate of $5.57 billion.Cerner also updated its Q1 guidance to $0.57-0.59 EPS.
A number of research firms have commented on CERN. Zacks Investment Research raised shares of Cerner from a hold rating to a buy rating and set a $71.00 price objective for the company in a research note on Wednesday. SunTrust Banks dropped their price objective on Cerner from $68.00 to $2.82 and set a hold rating on the stock in a report on Wednesday. BidaskClub downgraded Cerner from a hold rating to a sell rating in a report on Wednesday, January 24th. Evercore ISI initiated coverage on Cerner in a report on Thursday, January 18th. They issued an in-line rating and a $77.00 price objective on the stock. Finally, Cantor Fitzgerald increased their price objective on Cerner to $83.00 and gave the stock an overweight rating in a report on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and nine have given a buy rating to the company. Cerner has an average rating of Hold and a consensus target price of $65.99.
Shares of Cerner (NASDAQ CERN) traded down $1.17 during mid-day trading on Wednesday, reaching $62.82. The company’s stock had a trading volume of 879,557 shares, compared to its average volume of 2,249,233. Cerner has a one year low of $51.26 and a one year high of $73.86. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.75 and a current ratio of 2.77. The firm has a market capitalization of $21,078.43, a P/E ratio of 31.43, a PEG ratio of 1.86 and a beta of 0.90.
In other news, VP Michael R. Battaglioli sold 4,000 shares of the stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $69.89, for a total value of $279,560.00. Following the completion of the sale, the vice president now directly owns 4,000 shares of the company’s stock, valued at $279,560. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Clifford W. Illig sold 530,000 shares of the stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $65.54, for a total value of $34,736,200.00. Following the completion of the sale, the chairman now directly owns 1,229,719 shares of the company’s stock, valued at $80,595,783.26. The disclosure for this sale can be found here. Insiders sold 784,000 shares of company stock valued at $51,926,960 over the last three months. 13.11% of the stock is owned by company insiders.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.